Detalhe da pesquisa
1.
Emerging Cellular Therapies for Cancer.
Annu Rev Immunol
; 37: 145-171, 2019 04 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-30526160
2.
An NK-like CAR T cell transition in CAR T cell dysfunction.
Cell
; 184(25): 6081-6100.e26, 2021 12 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-34861191
3.
Distinct Signaling of Coreceptors Regulates Specific Metabolism Pathways and Impacts Memory Development in CAR T Cells.
Immunity
; 44(2): 380-90, 2016 Feb 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-26885860
4.
The role of chimeric antigen receptor T cells targeting more than one antigen in the treatment of B-cell malignancies.
Br J Haematol
; 204(5): 1649-1659, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38362778
5.
Distinct Signaling of Coreceptors Regulates Specific Metabolism Pathways and Impacts Memory Development in CAR T Cells.
Immunity
; 44(3): 712, 2016 03 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-28843072
6.
ICOS-based chimeric antigen receptors program bipolar TH17/TH1 cells.
Blood
; 124(7): 1070-80, 2014 Aug 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-24986688
7.
Genome Editing in CAR-T Cells Using CRISPR/Cas9 Technology.
Methods Mol Biol
; 2748: 151-165, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-38070114
8.
CAR affinity modulates the sensitivity of CAR-T cells to PD-1/PD-L1-mediated inhibition.
Nat Commun
; 15(1): 3552, 2024 Apr 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-38670972
9.
Genome Editing in Engineered T Cells for Cancer Immunotherapy.
Hum Gene Ther
; 34(17-18): 853-869, 2023 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-37694593
10.
mRNAs encoding IL-12 and a decoy-resistant variant of IL-18 synergize to engineer T cells for efficacious intratumoral adoptive immunotherapy.
Cell Rep Med
; : 100978, 2023 Mar 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-36933554
11.
Type I Interferon Signaling via the EGR2 Transcriptional Regulator Potentiates CAR T Cell-Intrinsic Dysfunction.
Cancer Discov
; 13(7): 1636-1655, 2023 07 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-37011008
12.
Soluble CD137 as a dynamic biomarker to monitor agonist CD137 immunotherapies.
J Immunother Cancer
; 10(3)2022 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-35236742
13.
Time 2EVOLVE: predicting efficacy of engineered T-cells - how far is the bench from the bedside?
J Immunother Cancer
; 10(5)2022 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-35577501
14.
Overcoming CAR-Mediated CD19 Downmodulation and Leukemia Relapse with T Lymphocytes Secreting Anti-CD19 T-cell Engagers.
Cancer Immunol Res
; 10(4): 498-511, 2022 04 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35362043
15.
Hyaluronidase expression by an oncolytic adenovirus enhances its intratumoral spread and suppresses tumor growth.
Mol Ther
; 18(7): 1275-83, 2010 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-20442708
16.
Verapamil enhances the antitumoral efficacy of oncolytic adenoviruses.
Mol Ther
; 18(5): 903-11, 2010 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-20179683
17.
Minimal RB-responsive E1A promoter modification to attain potency, selectivity, and transgene-arming capacity in oncolytic adenoviruses.
Mol Ther
; 18(11): 1960-71, 2010 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-20808288
18.
Choosing the Right Tool for Genetic Engineering: Clinical Lessons from Chimeric Antigen Receptor-T Cells.
Hum Gene Ther
; 32(19-20): 1044-1058, 2021 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-34662233
19.
Analysis of CAR-Mediated Tonic Signaling.
Methods Mol Biol
; 2086: 223-236, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-31707680
20.
Analysis of Antitumor Effects of CAR-T Cells in Mice with Solid Tumors.
Methods Mol Biol
; 2086: 251-271, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-31707682